Glyteer, derived from soybean tar, similarly activates AhR and has been demonstrated to impair IL4/STAT6 signaling in dendritic cells, reducing the production of Th2-attracting chemokines CCL17 and CCL22, thereby potentially alleviating AD symptoms [71,72]. This evidence concerns the gene IL4 and Alzheimer disease.